IRTC
iRhythm Technologies Inc
NASDAQ: IRTC · HEALTHCARE · MEDICAL DEVICES
$123.99
+0.19% today
Updated 2026-10-28
Market cap
$3.58B
P/E ratio
—
P/S ratio
4.34x
EPS (TTM)
$-0.42
Dividend yield
—
52W range
$101 – $212
Volume
0.5M
WallStSmart proprietary scores
32
out of 100
Grade: F
Strong Sell
Investment rating
7.3
Growth
B+5.0
Quality
C+3.5
Profitability
D5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
0.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →271 stocks currently score above 75
Price targets
Analyst target
$191.85
+54.73%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy13 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $37.52M — positive
+ Revenue growth 20.10% QoQ
Risks
- Altman Z 0.28 — distress zone
- Thin margins at -1.69%
- Debt/equity 3.91x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $410.92M | $492.68M | $591.84M | $747.14M | $825.34M | $0.9B |
| Net income | $-116.16M | $-123.41M | $-113.29M | $-44.55M | $-381000.00 | — |
| EPS | — | — | — | — | $-0.42 | $0.08 |
| Free cash flow | $-52.84M | $-90.53M | $-45.55M | $34.52M | $37.52M | — |
| Profit margin | -28.27% | -25.05% | -19.14% | -5.96% | -1.69% | — |
Peer comparison
Smart narrative
iRhythm Technologies Inc trades at $123.99. Our Smart Value Score of 32/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 0.28, it sits in the distress. TTM revenue stands at $825.34M. with profit margins at -1.69%.
Frequently asked questions
What is iRhythm Technologies Inc's stock price?
iRhythm Technologies Inc (IRTC) trades at $123.99, on a P/S of 4.3x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is iRhythm Technologies Inc overvalued?
iRhythm Technologies Inc carries a Smart Value Score of 32/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of iRhythm Technologies Inc (IRTC)?
The 12-month analyst consensus target is $191.85, about 54.7% above the current $123.99. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of IRTC by 2030?
Our research-backed model puts the 2030 base case at $60.39, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is iRhythm Technologies Inc's revenue?
iRhythm Technologies Inc's trailing twelve-month revenue is $825.34M, and our model projects it reaching about $1.75B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
iRhythm Technologies Inc's Altman Z-Score is 0.28, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.34x
ROE-17.23%
Beta1.46
50D MA$115.75
200D MA$125.21
Shares out0.03B
Float0.03B
Short ratio—
Avg volume0.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—